Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Aquestive Therapeutics, Inc.
IPO Date: July 23, 2018
Sector: Healthcare
Industry: Drug Manufacturers - Specialty and Generic
Market Cap: $399.3M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 3.74%
Avg Daily Range (30 D): $0.11 | 2.99%
Avg Daily Range (90 D): $0.11 | 3.51%
Institutional Daily Volume
Avg Daily Volume: .71M
Avg Daily Volume (30 D): 1.24M
Avg Daily Volume (90 D): 1.31M
Trade Size
Avg Trade Size (Sh.): 178
Avg Trade Size (Sh.) (30 D): 156
Avg Trade Size (Sh.) (90 D): 165
Institutional Trades
Total Inst.Trades: 126
Avg Inst. Trade: $1.94M
Avg Inst. Trade (30 D): $1.16M
Avg Inst. Trade (90 D): $1.53M
Avg Inst. Trade Volume: .5M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.17M
Avg Closing Trade (30 D): $1.47M
Avg Closing Trade (90 D): $1.06M
Avg Closing Volume: 515.39K
   
News
Jul 22, 2025 @ 11:00 AM
Aquestive Therapeutics Names Sherry Korczynski as ...
Source: Aquestive Therapeutics
Apr 9, 2025 @ 11:00 AM
Aquestive Therapeutics to Participate in Piper San...
Source: N/A
Feb 12, 2025 @ 12:00 PM
Aquestive Therapeutics to Present New Findings on ...
Source: N/A
Jun 27, 2024 @ 12:00 PM
Aquestive Therapeutics to Participate in Leerink P...
Source: Aquestive Therapeutics, Inc.
Jun 3, 2024 @ 12:00 PM
Aquestive Therapeutics Announces Executive Appoint...
Source: Aquestive Therapeutics, Inc.
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.59 $-.24 $-.19
Diluted EPS $-.59 $-.24 $-.19
Revenue $ 54.23M $ 8.72M $ 11.87M
Gross Profit $ 37.09M $ 5.07M $ 7.35M
Net Income / Loss $ -54.24M $ -22.93M $ -17.06M
Operating Income / Loss $ -41.18M $ -19.37M $ -13.58M
Cost of Revenue $ 17.14M $ 3.65M $ 4.52M
Net Cash Flow $ -26.54M $ -2.89M $ -6.35M
PE Ratio